2021 Q2 Portfolio Activity
In 2021 Q2, Johnson & Johnson Innovation - JJDC, Inc. maintained a portfolio of 21 distinct positions. The most significant new addition was CVRX, INC., now representing 10.01% of the total fund value. They heavily accumulated shares in FUSION PHARMACEUTICALS INC., increasing the position by 7308.1%. The fund also reduced its exposure to Fusion Pharmaceuticals Inc. by 98.7%.
Position History
hover any row below to update
Loading…
Total Positions
21
Quarter
2021 Q2
Top Holding
FATE (30.0%)
Top 10 Concentration
97.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21
Johnson & Johnson Innovation - JJDC, Inc. Full Holdings List — 2021 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FATE
FATE THERAPEUTI...
|
Healthcare | 29.98% | 36.08% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
3,379,064 | $293,269,000 | 2020 Q2 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 27.61% | 28.01% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
3,260,869 | $270,065,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 11.24% | 8.22% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
2,449,183 | $109,919,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
CVRX
CVRX, INC.
|
Healthcare | 10.01% | — |
#4
Prev: #—
|
8.0 |
—
|
3,495,575 | — |
NEW
|
3,495,575 | $97,876,000 | 2021 Q2 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 6.84% | 6.12% |
#5
1
Prev: #4
|
4.2 |
—
|
no change | no change |
P
S
|
1,629,173 | $66,878,000 | 2020 Q2 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
MGTX
MEIRAGTX HOLDIN...
|
Healthcare | 4.59% | 5.42% |
#6
Prev: #6
|
2.8 |
—
|
no change | no change |
P
S
|
2,898,550 | $44,928,000 | 2020 Q1 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
N/A
FUSION PHARMACE...
|
|
Unknown | 3.03% | 5.10% |
#7
Prev: #7
|
2.2 |
—
|
no change | no change |
P
S
|
3,670,516 | $29,658,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
VOR
VOR BIOPHARMA, ...
|
Healthcare | 2.05% | 6.00% |
#8
3
Prev: #5
|
1.8 |
—
|
no change | no change |
P
S
|
1,074,658 | $20,042,000 | 2021 Q1 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
N/A
BIOMX INC.
|
|
Unknown | 1.19% | 1.97% |
#9
1
Prev: #8
|
1.5 |
—
|
no change | no change |
P
S
|
2,133,402 | $11,648,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
N/A
THERAPEUTICS AC...
|
|
Unknown | 1.05% | — |
#10
Prev: #—
|
3.9 |
—
|
1,000,000 | — |
NEW
|
1,000,000 | $10,274,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
ACET
ADICET BIO, INC...
|
Healthcare | 0.77% | 1.23% |
#11
2
Prev: #9
|
1.3 |
—
|
no change | no change |
P
S
|
728,944 | $7,501,000 | 2020 Q3 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
PHAS
PHASEBIO PHARMA...
|
Unknown | 0.61% | 0.72% |
#12
2
Prev: #10
|
1.2 |
—
|
no change | no change |
P
S
|
1,607,044 | $5,978,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
ALDX
ALDEYRA THERAPE...
|
Healthcare | 0.46% | 0.61% |
#13
2
Prev: #11
|
1.2 |
—
|
no change | no change |
P
S
|
394,834 | $4,473,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
CSLT
CASTLIGHT HEALT...
|
Unknown | 0.22% | 0.16% |
#14
1
Prev: #13
|
1.1 |
—
|
no change | no change |
P
S
|
811,295 | $2,134,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
NPCE
NEUROPACE, INC.
|
Healthcare | 0.13% | — |
#15
Prev: #—
|
3.6 |
—
|
55,435 | — |
NEW
|
55,435 | $1,319,000 | 2021 Q2 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
N/A
ZYMERGEN INC.
|
|
Unknown | 0.07% | — |
#16
Prev: #—
|
3.5 |
—
|
16,553 | — |
NEW
|
16,553 | $662,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
N/A
TRACON PHARMACE...
|
|
Unknown | 0.06% | 0.09% |
#17
3
Prev: #14
|
1.0 |
—
|
no change | no change |
P
S
|
84,003 | $545,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
N/A
CATALYST BIOSCI...
|
|
Unknown | 0.03% | 0.04% |
#18
3
Prev: #15
|
1.0 |
—
|
no change | no change |
P
S
|
66,951 | $290,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
N/A
GRAYBUG VISION,...
|
|
Unknown | 0.03% | 0.04% |
#19
3
Prev: #16
|
1.0 |
—
|
no change | no change |
P
S
|
49,547 | $269,000 | — | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | ||
|
LUNG
PULMONX CORPORA...
|
Healthcare | 0.03% | 0.03% |
#20
3
Prev: #17
|
1.0 |
—
|
no change | no change |
P
S
|
5,639 | $249,000 | 2020 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) | |||
|
SENS
SENSEONICS HOLD...
|
Healthcare | 0.02% | 0.17% |
#21
9
Prev: #12
|
0.0 |
—
|
-437,648 | -88.9% |
P
S
|
54,621 | $210,000 | 2019 Q4 | 13F Filing | 2021-06-30 | 2021-08-14 (Est.) |
Showing 1-21 of 21 holdings